The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial
Titel:
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial
Auteur:
Bjarnason, Georg A. Knox, Jennifer J. Kollmannsberger, Christian K. Soulieres, Denis Ernst, D. Scott Zalewski, Pawel Canil, Christina M. Winquist, Eric Hotte, Sebastien J. North, Scott A. Heng, Daniel Yick Chin Macfarlane, Robyn Jane Venner, Peter M. Kapoor, Anil Hansen, Aaron R. Eigl, Bernhard J. Czaykowski, Piotr Boyd, Ben Wang, Lisa Basappa, Naveen S.